MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · IEX Real-Time Price · USD
4.670
-0.130 (-2.71%)
May 17, 2024, 4:00 PM EDT - Market closed
MaxCyte Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MaxCyte stock have an average target of 8.67, with a low estimate of 7.00 and a high estimate of 11. The average target predicts an increase of 85.65% from the current stock price of 4.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MaxCyte stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +135.55% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +135.55% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +71.31% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +49.89% | Nov 29, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +156.96% | Oct 5, 2023 |
Financial Forecast
Revenue This Year
34.91M
from 41.29M
Decreased by -15.46%
Revenue Next Year
46.43M
from 34.91M
Increased by 33.01%
EPS This Year
-0.51
from -0.37
EPS Next Year
-0.43
from -0.51
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.5M | 50.9M | 76.6M | 100.5M | 148.3M |
| Avg | 34.9M | 46.4M | 67.2M | 97.6M | 144.0M |
| Low | 32.3M | 39.8M | 57.7M | 93.8M | 138.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -6.7% | 45.9% | 64.9% | 49.5% | 51.8% |
| Avg | -15.5% | 33.0% | 44.8% | 45.2% | 47.5% |
| Low | -21.7% | 14.0% | 24.3% | 39.6% | 41.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.45 | -0.30 | -0.42 |
| Avg | -0.51 | -0.43 | -0.41 |
| Low | -0.58 | -0.53 | -0.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.